Nikkei (Canada) Marketing Limited   Report issue

For profit
Founded: Richmond BC Canada (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2018
NCT03589781
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Nikkei (Canada) Marketing Limited

Active Ingredients

Drugs in Other Trials (1)

reishi mushroom (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1